" class="no-js "lang="en-US"> Abbott Archives - Medtech Alert
Thursday, February 09, 2023

Sort by:

Date

Top Post

CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM

CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]

Abbott Announces US and European Approvals for New Technologies to Support Effective Treatment for Abnormal Heart Rhythms

Abbott has announced two approvals as part of its growing suite of electrophysiology products in […]

Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System

Abbott (NYSE: ABT) today announced it’s developing a new biowearable that will continuously monitor glucose and […]

New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies

Abbott (NYSE: ABT) today announced two late-breaking data presentations highlighting both TriClip™, a first-of-its kind minimally […]

Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise

Abbott (NYSE: ABT) announced today it has received FDA clearance for its Alinity™ m STI Assay. […]

Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes

Abbott (NYSE: ABT), CamDiab and Ypsomed today announced that they are partnering to develop and commercialize […]

Abbott Strengthens Its Connected Care Technologies with Latest Neurosphere™ Mypath™ Digital Health App

Abbott (NYSE: ABT) today announced that it has launched an upgraded version of its NeuroSphere™ […]

Abbott Senior Medical Director joins Nutromics as inaugural Chief Medical Officer

Australian and US MedTech start-up Nutromics (Nutromics or the Company), a global leader in DNA-based […]

Abbott Receives FDA Approval for Aveir™ Vr Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved […]

Abbott's CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-stage Heart Failure

Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded […]

Abbott Announces Future of Biowearables at Consumer Electronics Show

Making CES history, Abbott (NYSE: ABT) presented a keynote at the most influential tech event in the world, […]

  1. Toragen Announces Appointment of Chief Scientific Officer Read more
  2. First Citizens Bank Provides $31.2 Million for Acquisition of Cancer Treatment Center in Columbia, South Carolina Read more
  3. Roche Expands Collaboration with Janssen to Advance Personalised Healthcare Through Companion Diagnostics Read more
  4. ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Read more
  5. Superior HealthPlan and eFamilyCare Expand Partnership to Support Medicaid Members and Caregivers in Texas Read more